Shares of Abbott Laboratories ABT inched 0.39% higher to $114.76 Tuesday, on what proved to be an all-around positive trading ...

Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them ...

Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

Abbott Laboratories agreed to settle claims from a laid-off worker that the company engaged in pregnancy discrimination by ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $114.76 which represents a slight increase of $0.45 or 0.39% from the prior close of $114.31. The stock opened at $114.14 and ...

In a report released on December 20, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

M&T Bank Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% during the 3rd quarter, ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $114.23 which represents a slight increase of $1.81 or 1.61% from the prior close of $112.42. The stock opened at $112.64 and ...

Bengaluru: Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement ...

But more than that, you probably want to see it rise more than the market average. But Abbott Laboratories (NYSE:ABT) has fallen short of that second goal, with a share price rise of 31% over five ...